2 Minute Medicine Rewind May 18 – May 24, 2015
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Permissive ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Permissive ...
1. Survival for all stages of ovarian cancer improved significantly from 1975 to 2011 even after accounting for general advances ...
1. In patients with advanced, platinum-resistant ovarian cancer, combination therapy of a tyrosine kinase inhibitor, pazopanib, with paclitaxel significantly increased ...
1. In this meta-analysis of postmenopausal women with ovarian cancer, the risk of ovarian cancer was strongly associated with recent ...
1. In a retrospective review of over 600 patients with ovarian cancer, preoperative disease burden was the single most significant ...
Originally published by Harvard Health. What Is It? Ovarian cancer is the uncontrolled growth of abnormal cells in the ovaries. ...
1. In a small study of five women, vaginal DNA from tampons had a 60% sensitivity for detecting high-grade serous ...
1. Ultrasound- or computed tomography (CT)-guided ovarian mass biopsy yielded diagnostically sufficient samples with a sensitivity and specificity of 100% ...
1. A non-randomized control trial of 996 women at high risk for developing ovarian and tubal cancer found that 2.6% ...
1. Ovarian cancer patients randomized to receive paclitaxel + trebananib had improved progression-free survival versus paclitaxel + placebo. 2. Patients ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.